Back to search
FDAFDA · Food and drugs·Recall number D-0367-2021

Acyclovir Tablets, USP, 400 mg, 100 Tablets, Rx Only, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-227-01. Packaged in 150 cc white HDPE bottle

Published May 12, 2021 · Recall initiated: April 21, 2021

Summary

FDA records drug Class III recall D-0367-2021, published May 12, 2021 and initiated April 21, 2021. Recalling firm: Heritage Pharmaceuticals Inc; Status: Terminated; Reported quantity: 408 bottles; Lot: Lot A120036, Exp DEC 2023. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or Missing Lot and/or Exp Date

What to do

Voluntary: Firm initiated · Letter

Get an email if ACYCLOVIR has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ACYCLOVIR
Manufacturer
Heritage Pharmaceuticals Inc
Distributor
OH
UPC
0323155227017
Lot
Lot A120036, Exp DEC 2023
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Acyclovir Tablets, USP, 400 mg, 100 Tablets, Rx Only, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-227-01. Packaged in 150 cc white HDPE bottle recalled?

Yes. FDA published recall D-0367-2021 on May 12, 2021. Reported hazard: Labeling: Incorrect or Missing Lot and/or Exp Date

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ACYCLOVIR. UPC: 0323155227017.